These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31585361)

  • 21. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
    Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
    Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
    Lecordier S; Pons V; Rivest S; ElAli A
    Front Immunol; 2021; 12():813536. PubMed ID: 35173711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.
    Huang H; Nie S; Cao M; Marshall C; Gao J; Xiao N; Hu G; Xiao M
    Age (Dordr); 2016 Aug; 38(4):303-322. PubMed ID: 27439903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of treadmill exercise on autophagy in hippocampus of APP/PS1 transgenic mice.
    Zhao N; Zhang X; Song C; Yang Y; He B; Xu B
    Neuroreport; 2018 Jul; 29(10):819-825. PubMed ID: 29672446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of NLRP1 inflammasome improves autophagy dysfunction and Aβ disposition in APP/PS1 mice.
    Li X; Zhang H; Yang L; Dong X; Han Y; Su Y; Li W; Li W
    Behav Brain Funct; 2023 Apr; 19(1):7. PubMed ID: 37055801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice.
    Ou Z; Kong X; Sun X; He X; Zhang L; Gong Z; Huang J; Xu B; Long D; Li J; Li Q; Xu L; Xuan A
    Brain Behav Immun; 2018 Mar; 69():351-363. PubMed ID: 29253574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Particulate Matter Exposure Exacerbates Amyloid-β Plaque Deposition and Gliosis in APP/PS1 Mice.
    Sahu B; Mackos AR; Floden AM; Wold LE; Combs CK
    J Alzheimers Dis; 2021; 80(2):761-774. PubMed ID: 33554902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation, insulin signaling and cognitive function in aged APP/PS1 mice.
    Denver P; English A; McClean PL
    Brain Behav Immun; 2018 May; 70():423-434. PubMed ID: 29604345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatial Training Attenuates Long-Term Alzheimer's Disease-Related Pathogenic Processes in APP/PS1 Mice.
    Zhao Y; Bao J; Liu W; Gong X; Liang Z; Li W; Wu M; Xiao Y; Sun B; Wang X; Wang JZ; Wang J; Shu X
    J Alzheimers Dis; 2022; 85(4):1453-1466. PubMed ID: 34958016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Moxibustion improves learning-memory ability by promoting cellular autophagy and regulating autophagy-related proteins in hippocampus and cerebral cortex in APP/PS1 transgenic Alzheimer's disease mice].
    Zhu CF; Zhang LD; Song XG; Yang J; Pan HP; He CG; Yang K; Qin XF; Zhu WL
    Zhen Ci Yan Jiu; 2019 Apr; 44(4):235-41. PubMed ID: 31056874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
    Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
    Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
    Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ube2c-inhibition alleviated amyloid pathology and memory deficits in APP/PS1 mice model of AD.
    Li T; Su Q; Zhang Z; Zhang Y; Yang M; Wang Z; Guo J; Wang Z; Wu M; Cai H; Qi J
    Prog Neurobiol; 2022 Aug; 215():102298. PubMed ID: 35671859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.
    Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z
    Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DL0410 can reverse cognitive impairment, synaptic loss and reduce plaque load in APP/PS1 transgenic mice.
    Yang RY; Zhao G; Wang DM; Pang XC; Wang SB; Fang JS; Li C; Liu AL; Wu S; Du GH
    Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):15-26. PubMed ID: 26476132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subtle behavioral changes and increased prefrontal-hippocampal network synchronicity in APP
    Latif-Hernandez A; Shah D; Craessaerts K; Saido T; Saito T; De Strooper B; Van der Linden A; D'Hooge R
    Behav Brain Res; 2019 May; 364():431-441. PubMed ID: 29158112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to β-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment.
    Ostapchenko VG; Chen M; Guzman MS; Xie YF; Lavine N; Fan J; Beraldo FH; Martyn AC; Belrose JC; Mori Y; MacDonald JF; Prado VF; Prado MA; Jackson MF
    J Neurosci; 2015 Nov; 35(45):15157-69. PubMed ID: 26558786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.